StonvexLoading…
StonvexStonvexStonvexCore line items from ZSTK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $35.68M | $35.87M | $76.07M | $33.40M |
Operating Income | $-154.65M | $-8.93M | $-50.35M | $-47.22M |
Net Income | $-119.73M | $-15.91M | $-57.04M | $-52.41M |
EPS (Diluted) | $-43.49 | $-50.02 | $-7.75 | $-13.68 |
Total Assets | $130.24M | $26.23M | $23.63M | $80.99M |
Total Liabilities | $59.68M | $21.72M | $17.22M | $24.57M |
Cash & Equivalents | $5.60M | $5.22M | $4.35M | $8.94M |
Free Cash Flow OCF − CapEx | $-8.80M | $-5.17M | $-8.56M | $-17.23M |
Shares Outstanding | 1.05M | 478.00K | 8.94M | 6.78M |